A carregar...
Change in Expression of Survivin Caused by Using Oxaliplatin in HCT116 Colon Cancer Cells
PURPOSE: Oxaliplatin is a third-generation platinum compound, and it has no nephrotoxicity and has reduced bone marrow toxicity. Cancer cells that are resistant to cisplatin are sensitive to oxaliplatin. Oxaliplatin is used widely for the treatment of colon cancers. Recently, oxaliplatin was reporte...
Na minha lista:
| Main Authors: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
The Korean Society of Coloproctology
2010
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2998014/ https://ncbi.nlm.nih.gov/pubmed/21152225 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3393/jksc.2010.26.4.246 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|